Navigation Links
Stephen H. Friend, MD, PhD to Keynote at Defined Health's 9th Annual Therapeutic Insight Conference
Date:2/25/2009

FLORHAM PARK, N.J., Feb. 25 /PRNewswire/ -- Defined Health has announced the agenda and confirmed speakers for its 9th annual Therapeutic Insight conference. Therapeutic Insight 2009 ("TI2009") will take place on March 31- April 2, 2009, at The New York Marriott Downtown. The agenda, list of speakers and registration information along with content and attendee statistics from prior Therapeutic Insight conferences are available on the conference website, www.therapeuticinsight.com.

The following industry and key opinion leaders are among those who will discuss key industry issues and trends in oncology, pain, COPD, biologics and frailty in aging:

  • John Babiak, PhD, SVP, Discovery Technologies, PTC Therapeutics, Inc.
  • Karen Bernstein, PhD, Chairman & Editor-in-Chief, BioCentury
  • Maria Paola Chiesi, PhD, Corporate Marketing Head, Chiesi Farmaceutici
  • James F. Donohue, MD, Chief of Pulmonary Diseases and Critical Care Medicine, University of North Carolina at Chapel Hill School of Medicine
  • Andy Dray, PhD, Chief Scientist, AstraZeneca R & D, Montreal, Canada
  • Mark Edwards, Principal, Deloitte Recap LLC
  • Thomas M. Estok, President & CEO, Tragara Pharmaceuticals Inc.
  • Alan Ezekowitz, PhD, SVP & Franchise Head, BRIE, Merck Research Laboratories
  • Frederick Frank, Vice Chairman, Barclays Capital
  • Stephen H. Friend, MD, PhD, SVP & Franchise Head, Oncology, Merck Research Laboratories
    '/>"/>

SOURCE Defined Health
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Dr. John Stephen Osika, HIV/AIDS and Infectious Disease Expert, Joins Abt Associates
2. Genomic Health to Present at Stephens Fall Investment Conference
3. Neurofocus Appoints Stephen Kosslyn to Its Advisory Board
4. US Oncology Appoints Stephen Smith Vice President/General Manager Research and Personalized Science Services
5. BioNeutral Laboratories Announces the Appointment of Stephen Browand as a Director to Head Military, Homeland Security and Governmental Affairs
6. Immunosyn Announces Interview of CEO Stephen D. Ferrone by CEOCFO Interviews & News
7. Nano-Bio-Info-Cogno Revolutions to be Explored at Convergence08 Unconference - Forecaster Paul Saffo to Keynote
8. Christine Poon Will Keynote MichBio Expo
9. Innovative and Forward-Thinking Experts to Deliver Keynote Presentations at IBCs 13th Annual Drug Discovery & Development of Innovative Therapeutics World Congress
10. Merck & Co., Inc. Named Keynote Sponsor For Diversity Alliance For Sciences Inaugural Conference
11. National Stem Cell Holding, Inc. to Present Keynote Address at The Stem Cell Partnering Series Inaugural Meeting in San Diego
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... , June 18, 2013 ... ) has announced the addition of the ... [Liposomes, Microspheres, & Nanoparticles], Devices [Disposables & ... & Auto Injectors] & Therapeutics [Diabetes & ... report to their offering.      ...
(Date:6/18/2013)... AZ (PRWEB) June 18, 2013 ... services MeMD, Inc proudly announces the release of ... Health and Fitness ". , MeMD's goal was ... ever-changing landscape of Health 2.0, Health 3.0 and ... will likely transform medical care and the fitness ...
(Date:6/18/2013)... WA (PRWEB) June 18, 2013 Though ... -- 11,000, according to the U.S. Bureau of Labor Statistics ... increase of 24,000 per month. Most new health care jobs ... the hospital sector saw a loss of 6,000 jobs. Overall, ... outplacement consultancy firm Challenger, Gray & Christmas reported that a ...
(Date:6/18/2013)... Minneapolis, MN (PRWEB) June 18, 2013 ... the Saniclave 200 prevent the dangers of ... confusing features, like knobs, analog pressure gauges, hot surfaces ... older autoclave, or a new, modern autoclave, Revolutionary Science ... use fresh water. Older autoclave designs will recycle ...
Breaking Biology Technology:Injectable Drug Delivery Market by Formulations, Devices & Therapeutics - Global Forecasts to 2017 2Injectable Drug Delivery Market by Formulations, Devices & Therapeutics - Global Forecasts to 2017 3MeMD, Inc Releases Infographic Featuring the Top Eight Technologies that are Revolutionizing Health and Fitness Today 2MedZilla Employment Report for June 2013 -- Jobs in Health Care Grow, But at Slower Pace 2MedZilla Employment Report for June 2013 -- Jobs in Health Care Grow, But at Slower Pace 3How to Autoclave: Why the User Friendliness of the Saniclave 200 is So Important Today 2
... a dorm refrigerator in one of Himadri B. Pakrasi,s labs, a ... of red, blue and green LEDS. This isn,t just any ... is colored by a strain of blue-green bacteria that bubble off ... part because of their unique genetic endowment but also in part ...
... 14, 2010 BIOSAFE, Inc. has announced that ... water-based antimicrobial solutions and entered into a commercialization ... products containing BIOSAFE,s patented and exclusive antimicrobial polymer, ... protects surfaces from harmful and degrading effects of ...
... 2010 Tolerx, Inc., a biopharmaceutical company developing novel ... T cell activity, today announced that it has initiated ... tolerability, pharmacokinetic, and pharmacodynamic profiles of TRX518, a monoclonal ... T cells to more effectively attack cancer cells.   ...
Cached Biology Technology:Champion hydrogen-producing microbe 2Champion hydrogen-producing microbe 3Champion hydrogen-producing microbe 4Pittsburgh-based BIOSAFE Receives EPA Registration and Enters Into Commercialization Agreement with Union Springs Pharmaceuticals 2Pittsburgh-based BIOSAFE Receives EPA Registration and Enters Into Commercialization Agreement with Union Springs Pharmaceuticals 3Tolerx Initiates Phase 1 Clinical Trial of TRX518, a First-in-Class anti-GITR Antibody for the Treatment of Cancer 2Tolerx Initiates Phase 1 Clinical Trial of TRX518, a First-in-Class anti-GITR Antibody for the Treatment of Cancer 3
(Date:6/17/2013)... sugar alcohol produced by fungi, bacteria, and algae, is ... sweetener is also used in the medical field ... flush out excess fluids and used during surgery as ... the passage of other drugs. , Now Profs. Ehud ... of Molecular Microbiology and Biotechnology and the Sagol School ...
(Date:6/17/2013)... shale gas, is widespread across Pennsylvania, covering up to ... the Annals of the New York Academy of ... pollution from toxic chemicals, the building of well pads ... has engendered a great deal of controversy, largely because ... biological diversity and resources have scarcely been addressed in ...
(Date:6/16/2013)... a similar marine ecosystem crisis to those witnessed in ... to research published today in Nature Geoscience ., ... Newcastle, UK, Cologne, Frankfurt and GEOMAR-Kiel, confirms the link ... ecosystem during the mid-Cretaceous greenhouse period. It ... duration of the temperature change.,Analysing the geochemistry and micropaleontology ...
Breaking Biology News(10 mins):Artificial sweetener a potential treatment for Parkinson's disease 2Global cooling as significant as global warming 2
... (fMRI) is a powerful noninvasive tool for studying brain ... studies are carried out on adults, but this technique ... That potential is hampered, however, by a lack of ... the developing brain. Now, by studying rats, MIT neuroscientists ...
... Technology recently received a research grant from the ... Functional Polymers Modified Surfaces with Biofilm Sensitizing Ability. ... Department of Chemistry and Chemical Biology, will serve ... is an assemblage of microbial cells that is ...
... called for the guidance documents for the implementation of ... The consensus among the scientists and stakeholders who discussed ... Environmental Research (UFZ) in November was that the Directive ... taken further. The experts can already see that the ...
Cached Biology News:Using fMRI to study brain development 2Further development of Water Framework Directive necessary 2Further development of Water Framework Directive necessary 3
Mouse monoclonal antibody raised against a full length recombinant PPIL2. NCBI Entrez Gene ID = PPIL2...
Mouse monoclonal antibody raised against a full length recombinant SCGB3A2. NCBI Entrez Gene ID = SCGB3A2...
Mouse polyclonal antibody to BAG2 - BCL2-associated athanogene 2...
Mouse monoclonal antibody raised against a partial recombinant QPCT. NCBI Entrez Gene ID = QPCT...
Biology Products: